Portal Instruments signed multi-million dollar development agreement to advance PRIME NEXUS large volume reusable autoinjector to clinical readiness.
Develops software-defined drug delivery devices for biologics, including needle-free injection technology and reusable, software-controlled auto-injectors customized to medications
Develops software-defined drug delivery devices for biologics, including needle-free injection technology and reusable, software-controlled auto-injectors customized to medications. Its platform aims to improve the patient experience of self-injection and serves pharmaceutical partners.